Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users (Q34754918)

4 August 2017

Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users (English)

1 reference

4 August 2017

anti-retroviral agent

0 references

1 reference

Tim Rhodes

4

0 references

Robert S Hogg

object named as

Robert Hogg

series ordinal

6

0 references

Thomas Kerr

series ordinal

2

object named as

Thomas Kerr

1 reference

4 August 2017

8

Evan Wood

1 reference

4 August 2017

7

Julio Montaner

1 reference

4 August 2017

5

Silvia Guillemi

1 reference

4 August 2017

3

Jane Buxton

1 reference

4 August 2017

M J Milloy

1

1 reference

PubMed ID

21459814

4 August 2017

language of work or name

English

0 references

publication date

1 May 2011

1 reference

4 August 2017

7

1 reference

Journal of Infectious Diseases

inferred from page(s)

published in

1 reference

4 August 2017

203

1 reference

4 August 2017

9

1 reference

4 August 2017

1215-1221

1 reference

Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare

4 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069731

Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069731

Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069731

HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069731

Social and structural determinants of HAART access and adherence among injection drug users

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069731

Accessing antiretroviral therapy following release from prison.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069731

Homelessness and unstable housing associated with an increased risk of HIV and STI transmission among street-involved youth.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069731

Psychiatric disorders and repeat incarcerations: the revolving prison door.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069731

Recidivism in HIV-infected incarcerated adults: influence of the lack of a high school education

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069731

Antiretroviral treatment regimen outcomes among HIV-infected prisoners.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069731

Substance abuse and medication adherence among HIV-positive women with histories of child sexual abuse

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069731

When to initiate antiretroviral therapy in HIV-1-infected adults: a review for clinicians and patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069731

The social structural production of HIV risk among injecting drug users.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069731

Access and utilization of HIV treatment and services among women sex workers in Vancouver's Downtown Eastside.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069731

Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069731

Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069731

Determinants of survival following HIV-1 seroconversion after the introduction of HAART.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069731

Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069731

Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069731

Needle exchange is not enough: lessons from the Vancouver injecting drug use study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069731

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

7 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR032

Highly active antiretroviral therapy and survival in HIV-infected injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR032

The Impact of Adherence on CD4 Cell Count Responses Among HIV-Infected Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR032

Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR032

HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR032

Determinants of HAART discontinuation among injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR032

Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR032

Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR032

Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/L

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR032

Slower uptake of HIV antiretroviral therapy among Aboriginal injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR032

Simulation study of confounder-selection strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR032

Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR032

Validity of self-reported antiretroviral therapy use among injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR032

Ongoing drug use and outcomes from highly active antiretroviral therapy among injection drug users in a Canadian setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR032

Risk environments and drug harms: A social science for harm reduction approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR032

Burden of HIV infection among aboriginal injection drug users in Vancouver, British Columbia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR032

The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR032

Adherence to antiretroviral therapy: how much is enough?

21 January 2018

1 reference

12 December 2020

Adherence to triple therapy and viral load response

1 reference

12 December 2020

Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community

1 reference

12 December 2020

Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes

1 reference

12 December 2020

Identifiers

DOI

10.1093/INFDIS/JIR032

1 reference

4 August 2017

1 reference

4 August 2017

1 reference

PubMed ID

21459814